Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Decline Accept
Home › Fund moves › Calcimedica › CVI Investments, Inc. cut its CALC stake below 5% (4.9%) Fund moves
Why it stands out The holder reported owning less than 5%, which ends its duty to keep reporting this stake.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
All the details
Dates, kept separate
Date of the event that required the filing Sep 30, 2026
Reporting period Not applicable
Filed with the SEC Nov 16, 2026 passive 5% holder
Context Change vs prior quarter Undefined
Compared with the manager's prior 13F
Tracked managers with the same change NaN
For the same quarter
0001649553-26-000142
Data quality Verified: identifiers matched exactly
Around the same time Insider filing
Traded Nov 18 · filed 1 day later
Compensation award — excluded from discretionary-purchase analysis.
Fund moves
A Schedule 13G is filed by holders above 5% who say they will not try to influence the company. Index funds and large asset managers file most of them.
Insider filing
Traded Nov 3 · filed 2 days later
Compensation award — excluded from discretionary-purchase analysis.
The story around this disclosure Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
Aug 11, 2026 Company filing · Form 8-K · Results Reported its results Aug 19, 2026 Company filing · Form 8-K · Executive change, Shareholder vote Changed a top executive or board member, and held a shareholder vote “On August 19, 2026, CalciMedica, Inc. (the “Company”) held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”).” Aug 27, 2026 Company filing · Form 8-K · Bylaws or charter Changed its bylaws, charter or fiscal year What came next Oct 15, 2026 Company filing · Form 8-K · Executive change Changed a top executive or board member “On October 15, 2026, Stephen Bardin, the Chief Financial Officer, principal accounting officer and principal financial officer of CalciMedica, Inc. (the “Company”), provided notice of his resignation, to be effective immediately following the filing of the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2026, to pursue another professional opportunity.” Nov 10, 2026 Company filing · Form 8-K · Results Reported its results Nov 16, 2026 5% stake Stonepine Capital Management, LLC reported a passive stake (13G) of 8.1%